Jeffrey M. Jonas, President & CEO at Sage Therapeutics, Inc. (SAGE), sold 223,000 shares at $155.48 ($35.1M) on 2017-12-21, disclosed to the SEC on 2017-12-22.
Open-market sale of $35.1M SAGE by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.48 | 36,989 | $5.8M | 16.4% |
| 2 | $156.55 | 71,823 | $11.2M | 32.1% |
| 3 | $157.48 | 27,152 | $4.3M | 12.2% |
| 4 | $158.21 | 33,301 | $5.3M | 15.0% |
| 5 | $159.53 | 22,334 | $3.6M | 10.2% |
| 6 | $160.36 | 13,049 |
| $2.1M |
| 6.0% |
| 7 | $162.08 | 5,000 | $810K | 2.3% |
| 8 | $162.59 | 599 | $97K | 0.3% |
| 9 | $155.00 | 12,753 | $2.0M | 5.6% |
| Total | $157.31 avg | 223,000 | $35.1M | 100% |
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |